Search for: "PDL Biopharma Inc."
Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
19 Dec, 2007 4:04 pm by Donald Zuhn
By Christopher P. Singer -- In a December 17, 2007 press release, Otsuka Pharmaceutical Co., Ltd. and PDL BioPharma, Inc. announced a finalized agreement in which Otsuka acquires intellectual property related assets to IV Busulfex® (busulfan) from PDL. Under the agreement, Otsuka obtains rights to trademarks, patents, and other Busulfex-related...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
6 Apr 12:01 am by The Docket Navigator
... to the "the ANDA process and compounds . . . to the exclusion of the reality of the contemplated ANDA product's use." Rather, "the Court must look to the whole of the product, which means considering its ultimate useable state, as well as the ANDA-contemplated process and compound." PDL Biopharma, Inc. v. Sun Pharm. Indus. Ltd., 2-07-cv-01788 (NJD March 31, 2009, Opinion)
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
23 Dec, 2007 8:00 pm
... , Inc: 'Extended release formulation' and other terms defined in ANDA case: (Delaware IP Law) Busulfex (Busulfan) - Otsuka Pharmeceutical Co and PDL BioPharma ... (IP Law360), Claim constructions adopted in catheter patent suit between Medtronic Inc and Boston Scientific Corp: (IP Law360), Broadcom gets over $9m ... Law Blog), US International Trade Commission opening investigation into Qualcomm Inc. to determine whether the company is violating a ban on importing chips that allegedly infringe patents ...
IP Thinktank - http://duncanbucknell.com/blog
19 Dec, 2008 1:00 pm
... for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: 'Eli Lilly lobbies on counterfeiting and ... to detect tumours (Law360) US: MedImmune seeks invalidation of five patents owned by PDL BioPharma as part of licensing fight over respiratory drug for infants and related ... Canada: Federal Court rejects inequitable conduct doctrine in Canada: Janssen-Ortho Inc v Apotex (International Law Office) Nexium (Esomeprazole) - US: AstraZeneca to add ...
IP Thinktank - http://duncanbucknell.com/blog
9 Jan 3:00 am
... antitrust damages where Braintree had purchased patent blocking generic entry of drug competition: Braintree Laboratories, Inc v Schwarz Pharma, Inc (Hal Wegner) Mirapex (Pramipexole) - US: Boehringer appeals from judgment that Mirapex patent claims are invalid ... - US: AstraZeneca settles US patent litigation with Teva (The IP Factor) Soliris (Eculizamab) - US: Alexion to pay PDL BioPharma $25M as part of licensing deal resolving patent infringement suit over Soliris (Law360) Sprycel (Dasatinib) ...
IP Thinktank - http://duncanbucknell.com/blog
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck